Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Bioamber Company Profile (NASDAQ:BIOA)

Consensus Ratings for Bioamber (NASDAQ:BIOA) (?)
Ratings Breakdown: 2 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $16.00 (51.52% upside)

Analysts' Ratings History for Bioamber (NASDAQ:BIOA)
Show:
DateFirmActionRatingPrice TargetDetailsShare
11/24/2014BarclaysLower Price TargetOverweight$20.00 -> $16.00ViewTweet This Rating  Share This Rating on StockTwits
10/8/2014Canaccord GenuityInitiated CoverageBuy$16.00ViewTweet This Rating  Share This Rating on StockTwits
7/18/2014Societe GeneraleBoost Price Target$16.00ViewTweet This Rating  Share This Rating on StockTwits
7/17/2014BarclaysLower Price Target$22.00 -> $20.00ViewTweet This Rating  Share This Rating on StockTwits
7/10/2014BarclaysBoost Price TargetOverweight$13.00 -> $22.00ViewTweet This Rating  Share This Rating on StockTwits
1/27/2014BarclaysBoost Price TargetOverweight$10.70 -> $13.00ViewTweet This Rating  Share This Rating on StockTwits
1/10/2014BarclaysInitiated CoverageOverweight$10.70ViewTweet This Rating  Share This Rating on StockTwits
6/12/2013Societe GeneraleInitiated CoverageBuyViewTweet This Rating  Share This Rating on StockTwits
6/11/2013Credit SuisseInitiated CoverageOutperformViewTweet This Rating  Share This Rating on StockTwits
6/11/2013Pacific CrestInitiated CoverageSector PerformViewTweet This Rating  Share This Rating on StockTwits
(Data available from 11/27/2012 forward)